<DOC>
	<DOCNO>NCT00800969</DOCNO>
	<brief_summary>This prospective study include patient histologically proven cancer esophagogastric junction ( Siewert Type II III ) stomach . Aim study evaluate accuracy PET-CT preoperative assessment lymph node metastasis . The evaluation include combination standard diagnostic tool ( endoluminal ultrasound , CT diagnostic laparoscopy prior neoadjuvant therapy ) . Standardized D2-lymphadenectomy perform individual lymph node station ( Nr 1-12 accord Japanese classification ) histopathologically examine . Furthermore evaluate role PET-CT early metabolic response evaluation patient receive neoadjuvant chemotherapy . - Trial surgical intervention</brief_summary>
	<brief_title>Prospective Evaluation Preoperative Lymph Node Staging Patients With Cancer Esophagogastric Junction Stomach</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>Inclusion criterion : Histological prove adenocarcinoma stomach . Exclusion criterion : Recurrent gastric carcinoma No inform consent Previous malignancy ( exception : thyroid , bladder situ , Cervix situ )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Adenocarcinoma stomach esophagogastric junction</keyword>
</DOC>